Search This Blog

Translate

Saturday, 5 July 2014

Ebola outbreak: West African states agree strategy.

Ebola outbreak: West African states agree strategy.

Health workers take blood samples for Ebola virus testing at a screening tent in Kenema, Sierra Leone. 30 June 2014

workers, like these in Kenema, Sierra Leone, are taking blood samples to screen for the virus


Health ministers from 11 West African countries have adopted a common strategy to fight a deadly Ebola outbreak in the region.
At an emergency meeting in Ghana, ministers promised better collaboration to fight what has become the world's deadliest outbreak to date.
So far, 759 people have been infected with the virus in Guinea, Liberia and Sierra Leone and 467 of them have died.
The two-day meeting was called by the World Health Organization (WHO).
Under the new strategy, the WHO will open a sub-regional control centre in Guinea to co-ordinate technical support.

Related Stories



India to provide four free vaccines, including rotavirus.

India to provide four free vaccines, including rotavirus.

File photo of Indian children suffering from diarrhoea

Diarrhoea from rotavirus kills nearly 80,000 children in India every year

India will provide four new vaccines free of cost as part of a programme to reduce child mortality, Prime Minister Narendra Modi has said.
They include one for rotavirus, which kills thousands of children a year.
The disease causes dehydration and severe diarrhoea. It spreads via contaminated hands and surfaces, and is common in Asia and Africa.
The move brings to 13 the number of free vaccines provided against life threatening diseases.
"The introduction of four new life-saving vaccines will play a key role in reducing childhood and infant mortality and morbidity in the country," Mr Modi said in a statement.
"Many of these vaccines are already available through private practitioners to those who can afford them. The government will now ensure that the benefits of vaccination reach all sections of society, regardless of social and economic status."
The four new vaccines will combat rotavirus, rubella, polio and Japanese encephalitis.
Diarrhoea caused by rotavirus kills nearly 80,000 children each year and results in up to a million hospital admissions in India, the statement said.
Regular outbreaks of encephalitis also kill hundreds of children every year. 
A new adult vaccine against Japanese encephalitis will now be introduced in the 179 worst-affected districts in nine states.
Though India was declared polio free in March, it will introduce an injectable polio vaccine to "provide long lasting protection to the population against the virus," the statement said.

Related Stories


Friday, 4 July 2014

Scientists 'develop test for teen binge-drinking risk'

Scientists 'develop test for teen binge-drinking risk'.

Woman passed out with empties

Scientists claim to have developed a way of predicting which teenagers are likely to binge-drink.
A combination of 40 factors, including brain structure, personality and major life events, were used to produce the test.
It can predict, with 70% accuracy, which 14-year-olds are likely to binge-drink at 16.
But a simpler method would be needed to make the test practical because of the prohibitive costs of brain scans.
Studies have already looked for the differences between binge-drinking teenagers and those choosing a path of sobriety. 
Drinking wine
However, they cannot tease out what makes someone more likely to consume copious amounts of alcohol from the changes caused by the drink.
'Bunch of little things'
An international group of scientists have now conducted the largest study of its type to find a way of predicting which teenagers will go on to binge-drink.
They looked at a huge array of variables, including family history, exposure to alcohol, neuroticism, extravagance, conscientiousness and other personality traits, a suite of genes, brain volume, how the brain responds to reward and many more.
Dr Robert Whelan, of University College Dublin, told the BBC: "There is no one really big thing. It's a bunch of little things adding up to give you this prediction.
"There are three main areas: brain activity and brain structure; personality, so seeking out new things to do increases the risk, whereas conscious tends to make you less likely to binge-drink; and then life events, such as a boyfriend or girlfriend, is highly predictive."  
However, he cautioned the test would have limited value in testing one individual as it was not accurate enough.
"It is very broad, but you could identify a group of people - say, take 1,000 kids and find the top 200 at a higher risk - to give them special intervention."
Dr Whelan added that it was important to identify those at risk of binge drinking because studies had shown alcohol has "neurotoxic effects which carry on into adulthood".
However, brain scans cost thousands of pounds per person. A simplified version of the test, focusing on relatively cheap personality and family history factors, is more likely to be used.
Hugh Perry, chairman of the Medical Research Council neurosciences and mental health board, said: "Addiction and substance misuse is a major medical, social and economic problem for the UK.
"The UK government spends more than £15bn annually in meeting the cost of drug-related social and economic harm."
He said further research could "lead to breakthroughs in this field and provide compelling evidence to inform public health policy and lay the groundwork for the design of interventions".
The findings will also be applied to other fields, including drug abuse and smoking.

More on This Story

Related Stories


Thursday, 3 July 2014

Decline in trials for Alzheimer's disease

Decline in trials for Alzheimer's disease

Dementia

More than 99% of drug trials for Alzheimer's disease during the past decade have failed, according to a study.
There is an urgent need to increase the number of potential therapies being investigated, say US scientists.
Only one new medicine has been approved since 2004, they report in the journal Alzheimer's Research & Therapy.
The drug failure rate is troubling and higher than for other diseases such as cancer, says Alzheimer's Research UK.
Dr Jeffrey Cummings, of the Cleveland Clinic Lou Ruvo Center for Brain Health, in Las Vegas, and colleagues, examined a public website that records clinical trials.

Start Quote

The authors of the study highlight a worrying decline in the number of clinical trials for Alzheimer's treatments in more recent years”
Dr Simon Ridley Alzheimer's Research UK
Between 2002 and 2012, they found 99.6% of trials of drugs aimed at preventing, curing or improving the symptoms of Alzheimer's had failed or been discontinued.
This compares with a failure rate of 81% for cancer drugs.
The failure rate was "especially troubling" given the rising numbers of people with dementia, said Dr Simon Ridley, of Alzheimer's Research UK.
"The authors of the study highlight a worrying decline in the number of clinical trials for Alzheimer's treatments in more recent years," he said.
"There is a danger that the high failure rates of trials in the past will discourage pharmaceutical companies from investing in dementia research. 
"The only way we will successfully defeat dementia is to continue with high quality, innovative research, improve links with industry and increase investment in clinical trials."
Experimental models
Dr Eric Hill, of the School of Life and Health Sciences at Aston University, said more research was needed to understand the complex mechanisms behind the disease.
"The development of better experimental models that could be incorporated into a battery of tests, will not only help us to understand the changes that occur in the brains of Alzheimer's disease patients, but also provide tools for the development of new drug treatments that could slow or stop the onset of disease," he told BBC News.
Alzheimer's disease is the most common form of dementia.
It affects more than 820,000 people in the UK and costs the economy £23bn a year. 

More on This Story

Related Stories



Ebola 'out of control' in West Africa as health workers rush to trace 1,500 possible victims

Ebola 'out of control' in West Africa as health workers rush to trace 1,500 possible victims

Fear, mistrust of Western medicine and difficulties reaching remote areas mean hundreds of potentially infected people have not yet been found.

Health workers carry the body of an Ebola virus victim in Kenema, Sierra Leone

Hundreds of West Africans could be carrying the deadly Ebola virus and not know it, potentially infecting hundreds more, as cash-strapped governments and overwhelmed aid agencies struggle to contain the virus's spread.
At least 1,500 people have not yet been traced who are known to have come into contact with others confirmed or suspected to be infected with the haemorrhagic fever, Medecins Sans Frontieres (MSF) told The Telegraph.
Many more could be moving freely in the three countries battling the virus, Guinea, Liberia and Sierra Leone, but fear of the illness and mistrust of Western medicine means they refuse to come forward to speak to doctors.
The current outbreak is the worst ever. So far 467 people have died and health staff have identified at least 292 other suspected or confirmed cases.
Ebola is transmitted by coming into contact with bodily fluids of an infected person. It has no cure and as many as 90 per cent of its victims die, often from uncontrollable internal and external bleeding.

Related Articles

 

Gene linked to higher stroke and heart attack risk

Gene linked to higher stroke and heart attack risk.

Strokes are most commonly caused by clots blocking crucial blood supply to the brain

A blood clot in a vessel supplying the brain can starve the brain of oxygen

Researchers have identified a gene that may put people at greater risk of strokes and heart attacks.
Writing in PLOS ONE they say the gene fault may encourage the formation of blood clots - the ultimate cause of most heart attacks and strokes.
Scientists hope gene tests may help doctors one day to pinpoint individuals more likely to suffer these conditions.
But experts say lifestyle factors such as smoking and exercise have the greatest influence on risk.
Around one in 10 people in the Caucasian population carries this variation of the gene, named PIA2.
And researchers from King's College London reviewed more than 80 studies involving about 50,000 people - the largest analysis of this genetic fault to date.
 Threat to under-45s
They found individuals with PIA2 were more likely to have a stroke - caused by a blood clot blocking blood supply to the brain - than those without the gene.
Scientists calculate the gene increases a person's risk of having a stroke by 10-15%.
But how significant this increase is depends on an individual's baseline risk - influenced by factors such as smoking, diet, weight and exercise, the scientists say.
 Heart attacks are caused by a blockage to the blood vessels that carry oxygen to the heart.  
More than 100,000 heart attacks are recorded in the UK each year
And for people with two copies of the gene the risk rises by up to 70% from this baseline.
In a second study published in the same journal, the scientists show PIA2 is also linked to an increased risk of heart attacks in people under 45.
More research is needed to see whether this holds true for the whole population, they say.
About 150,000 people have a stroke in the UK each year and more than 100,000 heart attacks are recorded annually.
Both thrombotic strokes (the most common kind) and heart attacks are caused by blockage of blood vessels in the heart and brain - ultimately through the formation of clots.
'Devastating condition'
The faulty gene appears to affect a protein called glycoprotein IIIa - present on platelets, natural clotting cells in the blood.
Platelets help trigger the formation of clots to stop bleeding after injury. But scientists say carrying the gene may render them overactive.
They caution that overall the genes play a smaller role in risk than more established factors, such as high blood pressure and obesity.
But developing a genetic test could help predict people at highest risk, allowing doctors to suggest more potent medication or lifestyle changes, they say.
Prof Albert Ferro, of King's College London, who led the research, told the BBC: "We would now need to validate this test and see how useful it is in the clinical world."
Dr Shamim Quadir, of the Stroke Association, said: "These latest results are an important step forward in stroke research.
"We hope the findings from this study could lead to many more people who are most at risk of this devastating condition being identified.
'High cholesterol'
"However, if you have a family history of stroke or have any other risk factors, this does not mean the condition is inevitable. Regular exercise, eating a balanced diet and stopping smoking can be important steps to significantly reduce your stroke risk."
Prof Jeremy Pearson, of the British Heart Foundation, said: "It is as yet uncertain whether a genetic test to detect a variation in this protein would be beneficial for patients in everyday practice.
"All patients who are at risk should be monitored to see whether or not lifestyle changes or medication have a positive impact on the more standard major risk factors such as high blood pressure and high cholesterol."

Related Stories


Tuesday, 1 July 2014

Malaria parasite 'can manipulate body odour of mice'

Malaria parasite 'can manipulate body odour of mice'.

Illustration of mosquito biting skin

Malaria parasites may manipulate the body odour of the host to ensure reproduction.

Malaria parasites can manipulate the body odour of mice, research in the journal Proceedings of the National Academy of Sciences suggests.

Researchers believe parasites may change odours in order to help them with a key stage in their reproduction.
And scientists found the altered scent persists at a critical time when mice have no symptoms but remain infectious.
They are working on further trials to determine whether parasites can affect human smell too.
Scientists from the Swiss Federal Institute of Technology and Pennsylvania State University in the US studied the odour of mice with and without malaria for 45 days.
They found the scent of infected mice was markedly different to non-infected ones.
'Complex life-cycle'
The parasite did not completely alter the smell of the individual - instead it changed the level of compounds already present in mouse odour.

And this was particularly noticeable in mice which were still infectious but no longer showed any symptoms of the disease - corresponding to a crucial time in the life cycle of the parasite.
Prof Consuelo De Moraes of Pennsylvania State University and one of the lead authors of the research said: "There appears to be an overall elevation of several compounds that are attractive to mosquitoes."
The study showed mosquitoes were most attracted to mice when the parasites in their bodies were at a key point in their development - a stage when they needed to be passed back to a mosquito in order to reproduce.
Malaria parasites have a complex life-cycle with several stages. They need to develop and mature in both humans and mosquitoes.
Scientists believe parasites may manipulate the host's smell in order to ensure continued survival.
'Attractive to mosquitoes'
Researchers are now working on trials to see if this pattern of odour change can be traced in humans too.
Professor Mark Mescher of Pennsylvania State University who was also involved in the research told the BBC: "One of the major potential values of this research is if it can help us identify people who do not show symptoms of the disease. 
 Without symptoms people carry the disease without treatment and still transmit it.
"But there is still a long way to go. In mice we have a very controlled environment. In humans there are so many different factors at play - from diverse environments to diverse genes."
Dr James Logan of the London School of Hygiene and Tropical Medicine who was not involved in the research said:
"This is one of the first convincing studies that demonstrates a significant change in odour compounds from malaria-infected mammals can affect mosquito behaviour.
"The strength of this paper is in the experimental approaches used, combining analytical chemistry, statistical analyses and mosquito behaviour.
"However, this demonstration is in an animal model which may or may not relate to human beings infected with malaria."

More on This Story

Related Stories